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In the original publication, one of the last paragraphs should have read as follows:

A recent observation is that the prevalence of people who currently smoke cigarettes admitted for COVID-19 was low compared with the prevalence of smoking in the local general population. In China, of those hospitalized with Covid-19 only 6% were current smokers, whereas 27% of the general population of China smokes. (Farsalinos et al. 2020). In France, the smoker rate was 5% of COVID-19 admissions compared with a 25% smoker rate for the general French population. (Polosa and Caci 2020).

As a result, not all citations were correct and additionally two were incomplete. The new and correct references are published below.

Farsalinos K, Barbouni A, Niaura R (2020) Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Intern Emerg Med. 10.1007/s11739-020-02355-7

Instead of Geier and Geier (2020):

Polosa R, Caci G (2020) COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine. Intern Emerg Med. 10.1007/s11739-020-02361-9

Shi S, Lei S, Tang C, Wang K, Xia Z (2019) Melatonin attenuatesacute kidney ischemia / reperfusion injury in diabetic rats by activation of the SIRT1/Nrf2/HO-1 signaling pathway. Biosci Rep 39(1), BSR20181614. 10.1042/BSR20181614

Suba Z (2020) Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients. J Pharm Pharm Sci 23(1), 75--85. 10.18433/jpps31069

The online version of the original article can be found at 10.1007/s12192-020-01126-9
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